University of Minnesota. Driven to Discover.
Sierra Leone reports no cases after having 5 last week, and new funds for drugs and vaccines are announced.
As cases drop slightly, vaccine trials suffer from lack of patients. Also, the NIH announces a trial involving survivors.
Even hospitals that had done preparedness drills faced challenges, and the threat consumed a lot of resources.
The first two phase 1 trials of VSV-EBOV vaccine show good immune responses.
Funding will be used to continue trials of BCX4430 and prepare for its large-scale manufacture.
The findings clear the way for the next step, which may require a change in venue.
The virus may be more stable than a study in August found.
An American health worker is in critical condition, and several US health worker contacts, and one from the UK, have been flown home for observation.
Another American health worker has been infected with Ebola in West Africa's outbreak region.
With its Mar 7 launch date, the trial's main goal is to see if ring vaccination can knock down Ebola hot spots.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.